The global pharmacy benefit management market size reached USD 559.40 billion in 2023 and is projected to surpass around USD 1,218.98 billion by 2032 with a CAGR of 9.04% from 2023 to 2032.
Key Points
- North America led the global market with the highest market share in 2022.
- Asia Pacific region is estimated to expand the fastest CAGR between 2023 and 2032.
- By Service, the Specialty Pharmacy Services segment has held the largest market share of 34% in 2022.
- By Service Provider, the insurance companies segment captured the biggest revenue share in 2022.
- By Service Provider, the retail pharmacy segment is expected to expand at the fastest CAGR over the projected period.
The rapidly growing prevalence of various chronic diseases such as cancer, cardiovascular diseases, respiratory diseases, and diabetes among the global population, rising healthcare expenditure, growing adoption of healthcare insurances among the people, and rising penetration of the pharmacy benefit management service providers across the globe are the prominent factors that are expected to boost the growth of the global pharmacy benefit management market during the forecast period.
Full Report is Ready | Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1770
The rising costs of the drugs leads to unaffordability among the majority of the patients. The major role of the pharmacy benefit management service providers is to reduce the prices of such drugs and make it affordable for the patients. The growing demand for the pharmacy benefit management services among the drug manufacturers, retail pharmacies, and health insurance providers is boosting the demand for the pharmacy benefit management services across the globe. The rising awareness among the people regarding the benefits of health insurances is boosting the adoption of insurance policies which is spurring the growth of the market significantly.
Moreover, the rising penetration of the online pharmacies and the growing number of acquisitions and mergers between the pharmacy benefit managers and the health insurance companies is significantly contributing to the growth of the global pharmacy benefit management market.
Report Highlights
- Based on the service, the specialty pharmacies segment led the global market. This is attributed to the growing prevalence of chronic diseases and rising healthcare expenditure. The high prices of the specialty drugs are offered at low costs by the pharmacy benefit management service providers and hence led the growth of this segment in the market.
- By service providers, the insurance companies dominated the market in 2021. The rapidly growing number of acquisitions and mergers between the pharmacy benefit managers and the insurance companies is the major factor behind the bolstering growth of this segment in the global market.
Regional Snapshot
North America dominated the global pharmacy benefit management market in 2021. The increased prevalence of chronic diseases among the US population, higher healthcare expenditure, and high penetration of the health insurance companies in US has led to the growth of the North America pharmacy benefit management market. More than half of the US population has one or more chronic diseases. Total healthcare expenditure increased to US$4.1 trillion or an increase of 9.7% in 2020 as compared to the previous year, as per the data provided by the Centers for Medicare and Medicaid Services. The US is home to the leading drug manufacturers, pharmacy benefit management service providers, and insurers. These market participants have significantly contributed to the growth of the North America pharmacy benefit management market.
Asia Pacific is witnessing an increasing prevalence of various chronic diseases and rising healthcar4e expenditure. The growing adoption of the health insurances and regulatory reforms regarding the reimbursements are some of the prominent factors driving the Asia Pacific pharmacy benefit management market. The rapidly surging penetration on the various pharmacy benefit management providers in the region is expected to have a significant impact on the growth of the market during the forecast period.
Pharmacy Benefit Management Market Scope
Report Coverage | Details |
Growth Rate from 2023 to 2032 | CAGR of 9.04% |
Market Size in 2023 | USD 559.40 Billion |
Market Size by 2032 | USD 1,218.98 Billion |
Largest Market | North America |
Fastest Growing Region | Asia Pacific |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Service, Service Provider, Business Model, Region |
Pharmacy Benefit Management Market Dynamics
Driver
Rising pharmaceutical expenditures
The growing prevalence of chronic diseases is increasing the demand for the various treatment options. The leading pharma manufacturers are focusing on the development branded and high cost drugs for the treatment of the diseases. The rising healthcare expenditures due to the rising prices of various OTC drugs and prescription drugs has led to the increased demand for the pharmacy benefit management service providers who act as a middlemen and reduces the costs of the drugs for the insurance companies and makes it available to the patient at affordable rates. This factor is expected to boost the demand for the pharmacy benefit managers in the forthcoming years.
Restraint
No transparency in the earnings
The rising drug spending and surging number of prescription filings are the major growth drivers of the pharmacy benefit management market. There is a transparency issue associated with the business model of the pharmacy benefit managers that are a major concern. The revenue sources of the pharmacy benefit service providers are rarely disclosed to the insurers, drug manufacturers, and the retail pharmacies. It results in a huge portion of costs of the drugs going into the pockets of the service providers. This factor is expected to reduce the adoption of these services which may hamper the market growth.
Opportunity
Rise in the adoption of Artificial intelligence
The surging adoption of the machine learning technologies in the pharmacy benefit management services is shifting the preferences of the service providers from the traditional workflow to the new and advanced workflow. This results in companies to offer streamline supply chain, quick delivery, and serve to a large number of retail pharmacies and insurers.
Challenge
Lack of insurance policies adoption
In the developing and underdeveloped economies, there is a low penetration and adoption of the healthcare insurance policies among the population owing to their low literacy rates and low awareness regarding the benefits of insurance policies. This is a major challenge that may restrict the market growth.
Read Also: Digital Diabetes Management Market Size, Report By 2032
Pharmacy Benefit Management Market Players:
- CVS Health
- SS&C Technologies, Inc.
- Anthem Inc.
- Medimpact
- Express Scripts Holding Company
- Benecard Services, LLC
- CaptureRx Inc.
- Change Healthcare
- OptumRx, Inc.
- Cigna
Segments Covered in the Report
By Service
- Specialty Pharmacy Services
- Benefit Plan Design & Administration
- Formulary Management
- Pharmacy Claims Processing
- Others
By Service Provider
- Retail Pharmacies
- Insurance Companies
- Standalone Pharmacy Benefit Management Providers
By Business Model
- Government Health Programs
- Employer-sponsored Programs
- Health Insurance Management
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/
- Esoteric Testing Market Size to Hit USD 75.54 Bn by 2032 - July 17, 2024
- mRNA Therapeutics Market Size to Surpass USD 39.99 Bn By 2033 - July 17, 2024
- Acne Treatment Market Size to Hit USD 15.86 Bn by 2033 - July 17, 2024